Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials
Experts discuss how to navigate the complexities of adaptive trial designs and how ethics reviews uphold patient safety, ensure informed consent, and provide robust oversight.
Mastering Precision Oncology Start-Up: Reducing Screening Delays
Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
How In-Home Trials Can Shift The Pediatric Rare Disease Research Landscape
DCT solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens, but also strengthening the family-researcher connection.
Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays
Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.

The Past, Present, And Future Of Mobile Visits In DCTs
9/5/2024

From pandemic-driven adoption to a new era of patient-centric research, experts share insights and strategies for the future of decentralized clinical trials (DCTs).
Advancing Alzheimer's Disease Therapies
9/3/2025

By uniting scientific innovation with patient-focused execution, the next generation of alzheimer’s disease (AD) therapies has the potential to deliver a transformative impact on global health.
8 Critical Questions To Ask Your IRB
2/5/2025

This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.
The Impact Of AI On Mobile Visits
9/5/2024

Experts discuss the FDA's new AI guidance, global harmonization, and the ethical implications of AI in clinical trials. Discover the challenges and opportunities ahead.
The Difference Between Clinical Trial Auditing And Monitoring
4/28/2025

While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.

Patient Recruitment With A Patient-Centric Approach

At Avance Clinical, patients are our priority. We meticulously select experienced sites and clinics, alongside patient advocacy groups and communities to ensure optimal patient care and outcomes.
Precision Partnership For Obesity Clinical Trials

Accelerate obesity research with specialized expertise in GLP-1 trials. Our approach ensures rapid enrollment, high participant retention, and clean data through a patient-centered model.
Selecting The Right Pain Model For Early Phase Analgesic Trials

Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
Turnkey Solutions For Your Renal And Hepatic Impairment Studies

With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
Educate, Engage, Enroll: Accelerating Patient Recruitment

Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.